ToothWave Calculus Reduction and Accumulation Prevention Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-15

Study Completion Date

2020-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to evaluate the safety and efficacy of the home-use device ToothWave (Model H7001) for calculus reduction and the prevention of calculus accumulation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy of the ToothWave -12 Weeks Calculus Study

NCT04092075

Gingivitis Plaque Calculus, Dental

COMPLETED NA

ToothWave Plaque and Gingivitis Study

NCT03885323

Gingivitis Plaque Calculus, Dental

COMPLETED NA

Safety and Efficacy of the ToothWave Powered Toothbrush for Extrinsic Stain Reduction (Texas)

NCT04092062

Tooth Discoloration

COMPLETED NA

Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction

NCT03885609

Tooth Discoloration

COMPLETED NA

Self-selection Study of the Toothwave Toothbrush

NCT04023097

Gingivitis Plaque Calculus +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a parallel group, single-blind, randomized, and controlled prospective study aimed to evaluate the safety and efficacy of the ToothWave in calculus reduction and prevention of calculus accumulation.

Eligible subjects will undergo a dental prophylaxis, and will enter a two-month run-in phase. A Volpe-Manhold Index (V-MI) calculus examination will be per-formed at the end of the run-in phase. A minimum of 90 qualified subjects (completers) who will form at least 9 mm of calculus on the lingual surface of the mandibular anterior teeth and will qualify to continue participation ac-cording to the eligibility criteria and will be randomly assigned to either the ToothWave or the control brush (ADA-accepted powered TB) group. Subjects will be stratified according to calculus levels (which indicates the calculus growth rate). Stratification will also be conducted according to age, gender, and ethnic group. Subjects will brush twice daily, unsupervised, during a three-month test period, returning at Weeks 3, 6 and 12 for safety and V-MI examinations. An additional visit will be conducted at week 9, during which a supervised brushing will be conducted.

The study test phase will include a total of 168 treatment sessions and 5 clinic visits over a period of 12 weeks.

For each subject, assessment data will be collected at baseline, and at 3, 6 and 12 weeks of the test phase. The average data sets will be calculated for each group.

Treatment is defined as a timed 2 minutes of teeth brushing in a regular manner, twice a day (morning and evening). Brushing will be undertaken using the ToothWave and standard fluoride toothpaste. The control group will use a regular powered toothbrush and standard fluoride toothpaste.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis Plaque Calculus, Dental

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single blind prospective study

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

The Outcomes Assessors will not be exposed to the type of brush the subject is using or to the group they are assigned to (treatment or control).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group

The treatment is conducted with the ToothWave toothbrush Intervention: brushing with Radio frequency (RF)-utilizing powered toothbrush

Group Type EXPERIMENTAL

RF-utilizing powered toothbrush

Intervention Type DEVICE

RF-utilizing Powered toothbrush

Control group

Regular powered toothbrush Intervention: brushing with a regular powered toothbrush with no RF

Group Type EXPERIMENTAL

Control placebo with no RF

Intervention Type DEVICE

Placebo control, toothbrush with no RF

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RF-utilizing powered toothbrush

RF-utilizing Powered toothbrush

Intervention Type DEVICE

Control placebo with no RF

Placebo control, toothbrush with no RF

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RF toothbrush

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult subjects aged 18 years and older, that are in good health.
2. Subject must have a minimum of 16 natural teeth, including six mandibular anterior teeth with no crowns or veneers.
3. The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
4. The subjects should be willing to comply with the study procedures and schedule, including the follow up visits.
5. Subjects must demonstrate a propensity for calculus formation as evidenced by at least 9 mm of calculus on the lingual surfaces of the six mandibular teeth, following the 2-month run-in phase.

Exclusion Criteria

1. Subjects who had a medical condition requiring antibiotic premedication prior to dental procedures.
2. Regular users of a chlorhexidine mouthrinse.
3. Any oral condition or pathosis that could interfere with study compliance and/or examination procedures (e.g., widespread caries, chronic neglect, advanced periodontal dis-ease).
4. Current or history of oral cavity cancer or oropharyngeal cancer.
5. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
6. Pregnant or nursing by subject report.
7. Subjects that do not brush regularly.
8. Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes